Search

Search Constraints

You searched for: Author/Creator Vigliotti, Maria Luigia

Search Results

1. Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. Issue 11 (2nd November 2017)

2. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. Issue 4 (29th October 2012)

3. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Issue 4 (April 2014)

4. Nonpeghylated liposomal doxorubicin combination regimen (R‐COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. Issue 4 (9th July 2020)